CAHR’s industry-renowned Market Access 201 provides an advanced perspective of the various fields of activity involved in market access, from clinical trials to budget impact analysis and government relations. Market Access 201 expands upon the Market Access 101 course information and takes its ideas further, providing context and insight to better understand the issues facing market access professionals.

Market Access 201 features a mix of Canadian and International speakers discussing the current HTA and Market Access landscape in Canada, and how it fits in compared with broader global HTA and Market Access.

Speakers typically include staff (and former staff) from CADTH, ICER, and Canadian and global life sciences companies, and public and private payers. Gain information, insights and interpretations offered by industry specialists to empower your career in Market Access.

Market Access 201 is the second component required to obtain your Certified Market Access Professional (CMAP) Certification (learn more about CMAP here).